Fraiman, et al, original RCT data revealed greater risks of SAE outweighing clinical benefit since no reductions in hosp...
Sep 6th 2022 10:09pm EDT
Fraiman, et al, original RCT data revealed greater risks of SAE outweighing clinical benefit since no reductions in hospitalization and death in the trials program. This means that if properly evaluated in fall 2020, PFE/BNT should have never been EUA approved or gone on market. https://twitter.com/p_mcculloughmd/status/1567327712720687105?s=21&t=n0NittOqKEQ3MDBzuvN7vQ @PeterMcCulloughMDwww.PeterMcCulloughMD.com Powered by WPeMatico
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.